Effect of the Enrichment in c-Kit Stem Cell Potential of Foetal Human Amniotic Fluid Cells: Characterization from Single Cell Analysis to the Secretome Content

Human amniotic fluid cells (hAFSCs) are a fascinating foetal cell-type that have important stem cell characteristics; however, they are a heterogeneous population that ranges from totally differentiated or progenitor cells to highly multipotent stem cells. There is no single approach to isolating the stem cell component, but the selection of a subpopulation of hAFSCs expressing c-Kit is widely employed, while a deep characterization of the two populations is still lacking. Here we performed single-cell and bulk RNAseq analysis to compare the gene expression profiles of adherent amniotic fluid cells and their subpopulation c-Kit+. Information deriving from this high throughput technology on the transcriptome was then confirmed for specific targets with protein expression experiments and functional analysis. In particular, transcriptome profiling identified changes in cellular distribution among the different clusters that correlated with significant differential expression in pathways related to stemness, proliferation, and cell cycle checkpoints. These differences were validated by RT-PCR, immunofluorescence, WB, and cell cycle assays. Interestingly, the two populations produced secretomes with different immune-modulating and pro-regenerative potentials. Indeed, the presence of TGFβ, HGF, IDO was higher in EVs deriving from c-Kit+ cells, unlike IL-6. These results suggest the existence of deep intra-population differences that can influence the stemness profile of hAFSCs. This study represents a proof-of-concept of the importance of selecting c-Kit positive fractions with higher potential in regenerative medicine applications.

[1]  B. Young,et al.  Clinical potential of human amniotic fluid stem cells , 2022, Journal of perinatal medicine.

[2]  B. Ghinassi,et al.  Human mesenchymal amniotic fluid stem cells reveal an unexpected neuronal potential differentiating into functional spinal motor neurons , 2022, Frontiers in Cell and Developmental Biology.

[3]  E. Candi,et al.  The secretion profile of mesenchymal stem cells and potential applications in treating human diseases , 2022, Signal Transduction and Targeted Therapy.

[4]  M. Khacho,et al.  MITOCHONDRIA: Mitochondrial dynamics in the regulation of stem cells. , 2022, The international journal of biochemistry & cell biology.

[5]  M. Forcato,et al.  Unravelling Heterogeneity of Amplified Human Amniotic Fluid Stem Cells Sub-Populations , 2021, Cells.

[6]  Raphael Gottardo,et al.  Integrated analysis of multimodal single-cell data , 2020, Cell.

[7]  D. Chiego,et al.  SCF/C-Kit Signaling Induces Self-Renewal of Dental Pulp Stem Cells. , 2020, Journal of endodontics.

[8]  S. Kalantar,et al.  Investigating the expression of pluripotency-related genes in human amniotic fluid cells: A semi-quantitative comparison between different subpopulations, from primary to cultured amniocytes. , 2020, Reproductive biology.

[9]  Katherine Minter-Dykhouse,et al.  Energy Metabolism Regulates Stem Cell Pluripotency , 2020, Frontiers in Cell and Developmental Biology.

[10]  A. Arsenijević,et al.  Therapeutic Potential of Mesenchymal Stem Cells and Their Secretome in the Treatment of Glaucoma , 2019, Stem cells international.

[11]  H. Han,et al.  Role of HIF1α Regulatory Factors in Stem Cells , 2019, International journal of stem cells.

[12]  A. Lorenzini,et al.  Combination of Epigallocatechin Gallate and Sulforaphane Counteracts In Vitro Oxidative Stress and Delays Stemness Loss of Amniotic Fluid Stem Cells , 2018, Oxidative medicine and cellular longevity.

[13]  J. Hanna,et al.  MTCH2-mediated mitochondrial fusion drives exit from naïve pluripotency in embryonic stem cells , 2018, Nature Communications.

[14]  J. McCubrey,et al.  Nuclear Nox4 interaction with prelamin A is associated with nuclear redox control of stem cell aging , 2018, Aging.

[15]  Hyosang Lee,et al.  Mechanisms of protein toxicity in neurodegenerative diseases , 2018, Cellular and Molecular Life Sciences.

[16]  F. Beretti,et al.  Amniotic fluid stem cell exosomes: Therapeutic perspective , 2018, BioFactors.

[17]  J. Ježek,et al.  Reactive Oxygen Species and Mitochondrial Dynamics: The Yin and Yang of Mitochondrial Dysfunction and Cancer Progression , 2018, Antioxidants.

[18]  J. Deprest,et al.  The amniotic fluid as a source of mesenchymal stem cells with lung‐specific characteristics , 2017, Prenatal diagnosis.

[19]  F. Crea,et al.  Single-cell analysis of the fate of c-kit-positive bone marrow cells , 2017, npj Regenerative Medicine.

[20]  Andrew J. F. Valente,et al.  A simple ImageJ macro tool for analyzing mitochondrial network morphology in mammalian cell culture. , 2017, Acta histochemica.

[21]  A. F. Schinder,et al.  Role of Mitochondrial Metabolism in the Control of Early Lineage Progression and Aging Phenotypes in Adult Hippocampal Neurogenesis , 2017, Neuron.

[22]  S. Tiwari,et al.  Dynamin-related Protein 1 Inhibition Mitigates Bisphenol A-mediated Alterations in Mitochondrial Dynamics and Neural Stem Cell Proliferation and Differentiation* , 2016, The Journal of Biological Chemistry.

[23]  A. Hoffmann,et al.  Molecular and cellular characteristics of human and non-human primate multipotent stromal cells from the amnion and bone marrow during long term culture , 2015, Stem Cell Research & Therapy.

[24]  A. Caselli,et al.  Comparative proteomic analysis of two distinct stem-cell populations from human amniotic fluid. , 2015, Molecular bioSystems.

[25]  C. Zhang,et al.  Hypoxia and metabolic properties of hematopoietic stem cells. , 2014, Antioxidants & redox signaling.

[26]  A. Kazemi,et al.  Over expression of HIF-1α in human mesenchymal stem cells increases their supportive functions for hematopoietic stem cells in an experimental co-culture model , 2013, Hematology.

[27]  N. Sebire,et al.  Enrichment in c-Kit+ enhances mesodermal and neural differentiation of human chorionic placental cells. , 2013, Placenta.

[28]  J. Vermeesch,et al.  Valproic Acid Confers Functional Pluripotency to Human Amniotic Fluid Stem Cells in a Transgene-free Approach , 2012, Molecular therapy : the journal of the American Society of Gene Therapy.

[29]  P. de Coppi,et al.  CD117+ amniotic fluid stem cells , 2012, Organogenesis.

[30]  Cesar V Borlongan,et al.  Amniotic fluid stem cells: a promising therapeutic resource for cell-based regenerative therapy. , 2012, Current pharmaceutical design.

[31]  Jie Chen,et al.  Human amniotic fluid-derived c-kit+ and c-kit− stem cells: growth characteristics and some differentiation potential capacities comparison , 2012, Cytotechnology.

[32]  Min Zhang,et al.  Stem cell factor/c-kit signaling enhances invasion of pancreatic cancer cells via HIF-1α under normoxic condition. , 2011, Cancer letters.

[33]  A. Regev,et al.  An embryonic stem cell–like gene expression signature in poorly differentiated aggressive human tumors , 2008, Nature Genetics.

[34]  M. Ripoli,et al.  Role of reactive oxygen species as signal molecules in the pre-commitment phase of adult stem cells. , 2007, The Italian journal of biochemistry.

[35]  T. Kietzmann,et al.  Reactive Oxygen Species Activate the HIF-1&agr; Promoter Via a Functional NF&kgr;B Site , 2007 .

[36]  A. Santel,et al.  Control of mitochondrial morphology by a human mitofusin. , 2001, Journal of cell science.

[37]  N. Sebire,et al.  Enrichment in c-Kit improved differentiation potential of amniotic membrane progenitor/stem cells. , 2015, Placenta.

[38]  Thomas R. Gingeras,et al.  STAR: ultrafast universal RNA-seq aligner , 2013, Bioinform..

[39]  A. Atala,et al.  Stem cells derived from amniotic fluid: new potentials in regenerative medicine. , 2009, Reproductive biomedicine online.

[40]  T. Kietzmann,et al.  Reactive oxygen species activate the HIF-1alpha promoter via a functional NFkappaB site. , 2007, Arteriosclerosis, thrombosis, and vascular biology.